Walleye Capital’s Prothena Corp PRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-200
Closed -$1.94K 5089
2026
Q1
$1.94K Sell
200
-35,100
-99% -$322K ﹤0.01% 4239
2025
Q4
$337K Sell
35,300
-12,000
-25% -$122K ﹤0.01% 3217
2025
Q3
$462K Buy
47,300
+15,400
+48% +$118K ﹤0.01% 2680
2025
Q2
$194K Buy
+31,900
New +$239K ﹤0.01% 3392
2024
Q3
Sell
-800
Closed -$16.5K 5749
2024
Q2
$16.5K Sell
800
-5,900
-88% -$128K ﹤0.01% 5147
2024
Q1
$166K Buy
+6,700
New +$199K ﹤0.01% 4090
2023
Q3
Sell
-2,900
Closed -$198K 5231
2023
Q2
$198K Buy
+2,900
New +$187K ﹤0.01% 3088
2019
Q2
Sell
-5,300
Closed -$64K 1967
2019
Q1
$64K Buy
+5,300
New +$66.2K 0.01% 1158

Other funds holding PRTA

Walleye Capital's PRTA Position: Q2 2026 in Review

Walleye Capital sold out of Prothena Corp (PRTA) in Q2 2026, closing a stake of 277,168 shares — an estimated $2.69M sold.

Walleye Capital first reported a position in PRTA in Q1 2019 and held it in 10 quarters. The position peaked at $3.8M in Q2 2023. 187 funds tracked by Wall St. Rank hold PRTA as of Q2 2026.

  • Walleye Capital reported no remaining Prothena Corp position as of Q2 2026 after selling out during the quarter.
  • Walleye Capital sold 277,168 Prothena Corp shares in Q2 2026, an estimated $2.69M.
  • Walleye Capital first reported a position in Prothena Corp in Q1 2019 and held it in 10 quarters.
  • Walleye Capital's Prothena Corp position peaked at $3.8M in Q2 2023.
  • 187 funds tracked by Wall St. Rank held Prothena Corp as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.